FDA Takes Action to Stop Marketing of Unapproved Hydrocodone Products (U. S. Food and Drug Administration)
The U.S. Food and Drug Administration today announced its intention to take enforcement action against companies marketing unapproved prescription drug products containing hydrocodone, a narcotic widely used to treat pain and suppress coughs. The action does not affect other hydrocodone formulations, which have FDA approval.